OncologyEGFR tyrosine kinase inhibitorMade to order

Erlotinib hydrochloride

Also known as Tarceva

An EGFR tyrosine kinase inhibitor for non-small cell lung cancer and pancreatic cancer. Available on campaign basis for validated commercial programmes.

Request a sample Request spec sheet

Full specification

Identity, quality, and supply.

INN: Erlotinib hydrochloride
CAS number: 183319-69-9
Molecular formula: C22H24ClN3O4
Molecular weight: 429.9 g/mol
Therapeutic area: Oncology
Therapeutic class: EGFR tyrosine kinase inhibitor
Supplied as: API
Available scale: Pilot (up to 25 kg)
Stock status: Made to order
Storage: As per COA
Packaging: HDPE drums, 5 kg net weight
Brand names: Tarceva

Highlights

What buyers care about.

Cytotoxic-suite manufacturing
Form B polymorph control

Request a sample

Enquiring about Erlotinib hydrochloride · CAS 183319-69-9

First nameLast nameWork emailCompanyPhoneCountryRequested quantityMessage

NDAs signed within one business day. No sales spam — ever.

Related molecules

Other molecules in Oncology.

Full catalogue

C29H31N7O·CH4O3S

Imatinib mesylate

CAS 220127-57-1 · MW 589.7 g/mol

View spec

C17H11N5

Letrozole

CAS 112809-51-5 · MW 285.3 g/mol

View spec

Prefer to skip the form?Email admin@operantworld.com +91 81071 99052